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Fungi have a remarkable capacity to take up iron when present in any of a wide variety of forms, which include free iron ions, low-affinity iron
chelates, siderophore–iron chelates, transferrin, heme, and hemoglobin. Appropriately, these unicellular eukaryotes express a variety of iron
uptake systems, some of which are unique to fungi and some of which are present in plants and animals, as well. The reductive system of uptake
relies upon the external reduction of ferric salts, chelates, and proteins prior to uptake by a high-affinity, ferrous-specific, oxidase/permease
complex. This system recognizes a broad range of substrates. The non-reductive system exhibits specificity for siderophore–iron chelates, and
transporters of this system exhibit multiple substrate-dependent intracellular trafficking events.
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Ancient unicellular organisms began their evolution in a
reducing environment that was devoid of molecular oxygen and
rich in ferrous iron [1]. Modern microorganisms reflect these
origins in that virtually all exhibit a requirement for this
transition metal. Iron, often in the form of heme or iron–sulfur
clusters, is used in many essential biochemical processes, such
as the reduction of atmospheric nitrogen, the synthesis of
deoxyribonucleotides, respiration, the tricarboxylic acid cycle,
and the synthesis of numerous small molecules such as amino
acids, lipids and sterols. Iron can stably occupy multiple valence
states, and this capacity to gain or lose electrons accounts for its
presence in so many enzymatic reactions involving the transfer
of electrons. This reliance on iron comes at a cost, however. In
an aerobic environment, iron is largely present in the oxidized,
ferric state, which forms colloid particles of oxyhydroxides that
have a solubility of only 10−9 M at neutral pH [2,3]. Although
the solubility of Fe(OH)3 is reported to be 10
−18 M, Fe(OH)2
+ is
the principle soluble form of iron at pH 7, and has a solubility of
1.4×10−9. This is well below the concentration where most iron
uptake systems operate; therefore, unicellular organisms have⁎ Tel.: +301 435 4018; fax: +301 402 0491.
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strategies are available to microorganisms to increase the
solubility of iron, (1) acidification of the environment, (2)
reduction of ferric iron to the more soluble ferrous form, and (3)
secretion of soluble iron-chelating molecules. Fungi employ all
of these strategies to varying extents, and often employ multiple
distinct iron-uptake systems simultaneously.
Pathogenic fungi also exhibit strategies to obtain iron from
their host. In mammals, free iron is essentially unavailable in
blood and extracellular fluids, as circulating transferrin binds
ferric iron with a stability constant of 10−20 M [4]. Therefore
pathogenic fungi have evolved strategies for obtaining iron
from transferrin and from the most abundant source of iron in
mammals—hemoglobin.
In the intracellular environment, iron is largely present in the
reduced, ferrous state. While this form is readily soluble, it is
also highly reactive, and can catalyze the formation of reactive
oxygen species within the cell. Thus, the cellular systems
involved in the uptake and utilization of iron are precisely
regulated according to the availability of iron and the cellular
requirements for iron. Iron metabolism has been studied in
greatest detail in the model organism Saccharomyces cerevisiae,
also known as baker's yeast, although molecular details of iron
metabolism in other fungi are beginning to emerge. S. cerevisiae
can thrive in environments where the bioavailable iron is
Table 1
Proteins involved in iron transport in Saccharomyces cerevisiae
Gene Name Location Function
YDR534C FIT1 Cell wall Siderophore binding
YOR382W FIT2 Cell wall Siderophore binding
YOR383C FIT3 Cell wall Siderophore binding
YLR214W FRE1 Plasma membrane Metalloreductase
YKL220C FRE2 Plasma membrane Metalloreductase
YOR381W FRE3 Plasma membrane Siderophore reductase
YNR060W FRE4 ? ? reductase
YOR384W FRE5 ? ? reductase
YLL051C FRE6 Vacuole ? reductase
YMR058W FET3 Plasma membrane Multicopper oxidase,
Fe(II) uptake
YER145C FTR1 Plasma membrane Permease, Fe(II) uptake
YHL040C ARN1 Endosome,
Plasma membrane
Ferrichrome transport
YHL047C ARN2/TAF1 ? TAFC transport
YEL065W ARN3/SIT1 Endosome,
Plasma membrane
Hydroxamate siderophore
transport
YOL158C ARN4/ENB1 ? Enterobactin transport
YNL259C ATX1 Cytosol Cu chaperone, deliver
Cu to Ccc2p
YDR270W CCC2 Post-Golgi vesicle Cu transport to vesicles
YMR319C FET4 Plasma membrane Fe(II) transport
YOL122C SMF1 Plasma membrane Mn, Fe(II), Cu transport
YHR050W SMF2 Vesicles Mn, ?Fe(II) transport
YLR034C SMF3 Vacuole Fe transport
YFL041W FET5 Vacuole Multicopper oxidase,
Fe(II) transport
YBR207W FTH1 Vacuole Permease, Fe(II) transport
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availability. In general, high-affinity iron acquisition systems
are homeostatically regulated. That is, under conditions of iron
scarcity, iron acquisition systems are expressed at high levels,
and under conditions of iron abundance, these systems are
expressed at very low levels. In S. cerevisiae, these systems are
regulated by the iron-dependent transcriptional activators Aft1p
and Aft2p, which are described in detail in an accompanying
review. Fig. 1 summarizes the iron acquisition systems of S.
cerevisiae, and a compilation of the proteins involved in yeast
iron transport, along with their functions and subcellular
locations, is presented in Table 1. This review will focus on
the strategies exhibited by this organism and other fungi to
acquire iron from the environment.
2. The role of the cell wall in iron uptake
Before the yeast cell can take up iron in any form, the iron
must first traverse the cell wall. The fungal cell wall is a highly
dynamic structure that is composed of a latticework of β-1,3-
glucan, β-1,6-glucan, and chitin, and an outer layer of
mannoproteins [5]. The mannoprotein composition and perme-
ability of the cell wall change dramatically under different
growth conditions, which may alter the passage of nutrients
through the cell wall to the periplasmic space and plasma
membrane. S. cerevisiae retains significant quantities of iron-
binding molecules called siderophores (discussed in SectionFig. 1. Iron uptake systems of S. cerevisiae. The plasma membrane of yeast is
surrounded by a porous cell wall that protects the cell from osmotic lysis and
excludes larger macromolecules. The FIT mannoproteins of the cell wall
facilitate retention of siderophore–iron in the cell wall, but are not required for
siderophore uptake. Many siderophores likely cross the cell wall through non-
specific pores. Siderophore-bound iron can be reduced and released from the
siderophore by the FRE reductases. Ferric iron salts and low-affinity chelates are
also reduced by the FRE reductases prior to uptake. Reduced iron can then be
taken up through either the high-affinity ferrous iron transporter (the Fet3p and
Ftr1p complex) or through low affinity transporters (Fet4, Smf1). Fet3p is a
ferroxidase that requires copper for function. Fet3p does not become functional
until it is loaded with copper intracellularly through the activities of the copper
chaperone Atx1p and the copper transporter Ccc2p. Although the Fet3p/ Ftr1p
complex mediates uptake of much of the iron released from siderophores, there
is also another uptake route. Intact siderophore–iron chelates can be taken up via
members of the ARN transporter family. The Arn transporter binds the ferric
siderophore, and the transporter–siderophore complex undergoes endocytosis
prior to translocation of the ferric siderophore chelate across the membrane.4.1) in the cell wall and periplasmic space [6], which can be
released upon enzymatic digestion of the cell wall [7]. Iron
depletion induces very high levels of expression of a family of
three cell wall mannoproteins, and these are termed Fit1p, Fit2p,
and Fit3p (for Facilitator of iron transport) [7]. These proteins
contribute to the retention of siderophore–iron chelates in the
cell wall and enhance the uptake of iron bound to certain
siderophores. Deletion of the FIT genes results in a ~50%
decrease in cell wall-associated ferrichrome. Strains bearing
deletions of FIT1, FIT2, or FIT3 also exhibit lower levels of
uptake of the siderophores ferrichrome and ferrioxamine B. The
precise mechanism by which the FIT genes enhance iron uptake
is not known, but may involve facilitating the passage of bulky
iron-siderophore chelates through the cell wall or involve
increasing the concentration of siderophore in the periplasmic
space. The cell wall is also important in the uptake of heme (see
Section 5).
3. Reductive systems of iron uptake
Metal transporters typically recognize substrates of a single
valence and do not transport metals of other valences. For
example, while some ferrous iron (Fe2+) transporters may
recognize Mn2+ or Cu2+, they do not recognize or transport
ferric iron (Fe3+). How metal transporters select the appropriate
substrate for transport is not completely understood, but
probably involves both the size of the ionic species and the
binding characteristics. For this reason, ferric iron must be
reduced to ferrous iron before it can be taken up through a
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genetically separate systems of iron uptake, a reductive system
and a non-reductive system. The reductive system entails a two-
step process that begins with the reduction of ferric iron to the
ferrous form at the plasma membrane followed by the uptake of
the reduced, ferrous iron by a high-affinity, ferrous-specific
transporter complex. Many species of fungi express reductive
systems similar to that of S. cerevisiae. This system of iron
uptake has been elegantly reviewed in detail [8,9], and will be
described briefly here.
3.1. The FRE family of reductases
FRE1 and FRE2 encode plasma membrane metalloreduc-
tases that can reduce oxidized forms of both iron and copper, yet
exhibit activity towards other non-metallic compounds that can
act as one-electron acceptors [10–16]. The FRE reductases are
polytopic integral membrane proteins that contain binding sites
for heme, FAD, and NADPH, and Fre1p has been shown to bind
heme as a b-type cytochrome [17]. FRE1 and FRE2 encode
almost all of the ferric reductase activity on yeast cells, yet the
FRE family of reductases contains seven additional members
with significant homology to FRE2 [18,19]. FRE1, 2, 3, 4, 5,
and 6 are transcribed when cells are iron depleted and FRE1 and
7 are transcribed when cells are copper depleted. Iron and
copper do not affect the transcription of two unnamed FRE
family members (YGL160W and YLR047C). Fre3p is
expressed on the plasma membrane and exhibits some
siderophore reductase activity [20]. Preliminary data suggest
that Fre6p may be expressed on the vacuolar membrane and be
involved in the reductive export of iron to the cytosol (D.
Kosman and A. Singh, personal communication). The remain-
ing FRE family members remain uncharacterized, and may also
be involved in intracellular metal reduction and transport.
Although Fre1 and Fre2p were initially characterized as
ferric citrate reductases, their broad substrate specificity enables
yeast to take up iron from a large number of ferric sources.
Siderophores specifically bind ferric iron with high affinity, yet
have relatively low affinity for ferrous iron. Therefore,
reduction of ferric-siderophore complexes results in the release
of ferrous iron, which can be taken up by the ferrous-specific
transporter [21,22]. Fre1p and Fre2p can catalyze the reduction
of a variety of iron-siderophore chelates, including hydro-
xamates, such as ferrichrome and ferrioxamine B, and
catecholates, such as enterobactin [20,23]. Fre3p encodes a
plasma membrane reductase that can catalyze the reductive
uptake of iron bound to hydroxamate siderophores, and Fre4p
can catalyze uptake from the di-hydroxamate rhodotorulic acid
[20]. The standard reduction potentials of ferric siderophores
exceed those of physiologic reductants, such as NADPH,
prompting some investigators to conclude that reduction of
ferric–siderophore complexes at the cell surface is kinetically
unfavorable and unlikely to occur. However, coupling the
ferric–siderophore reduction to a ferrous iron-specific “trap,”
such as a ferrous-specific ligand, especially at reduced pH and
in a hydrophobic environment, can shift the effective reduction
potential into the range of physiologic reductants [24,25].Therefore, reduction of ferric siderophores can take place in
vivo in the presence of a ferrous iron “trap” (such as a ferrous
iron transporter), a lipid environment, and reduced pH. All of
these conditions are present on the surface of an iron-depleted
yeast cell. Ferric iron-binding proteins are also substrates for the
FRE reductases, as the reductive uptake system of Candida
albicans is necessary for this fungus to acquire iron from the
mammalian iron-binding protein, diferric transferrin [26].
Similar to siderophores, transferrin has a high affinity for ferric
iron, but a relatively low affinity for ferrous iron, and reduction
of ferric-transferrin results in the release of ferrous iron.
3.2. The Fet3p/Ftr1p oxidase/permease complex
Reduced iron is taken up through a high-affinity transport
complex that consists of a multicopper ferroxidase (Fet3p) [27]
and a permease (Ftr1p) [28]. This transport complex operates
with an apparent Km of 0.2 μM [11], which is an unusually high
affinity for a small molecule transport system, and this allows
yeast to thrive in environments containing very low concentra-
tions of iron. The ferrous iron to be transported is first oxidized
by Fet3p in a reaction that is copper-dependent and requires
molecular oxygen [29–32]. The ferric iron is then transferred to
the cytosol via the Ftr1p permease. The mechanism of the
transfer of ferric iron to Ftr1p, as well as the advantage gained
by this redox coupling, is unclear. Furthermore, the oxidation
step is obligatory, as ferric iron is not a substrate for the oxidase/
permease complex and mutant forms of Fet3p lacking oxidase
activity will not support iron transport [33]. The oxidase
reaction is clearly copper dependent, and four copper ions are
post-translationally inserted into Fet3p in a post-Golgi com-
partment of the secretory pathway [34]. The copper chaperone
Atx1p binds cytosolic copper and delivers it to Ccc2p [35], the
microsomal copper transporter that pumps copper into the
lumen of the post-Golgi vesicle [36]. Both of these proteins are
required for copper insertion into Fet3p, as are adequate cellular
copper levels [37] and a properly functioning secretory
pathway. Although Atx1p and Ccc2p specifically recognize
copper for binding and transport, respectively, they are
expressed in response to iron depletion, not copper depletion,
indicating that their primary role is in Fet3-dependent iron
uptake.
Fet3p and Ftr1p are assembled into a stable complex
prior to trafficking to the cell surface, and both components
are retained by quality control systems in the endoplasmic
reticulum if they are expressed in the absence of their
protein partner [28]. Turnover of the Fet3p/Ftr1p complex is
regulated, and in the presence of high levels of iron the
complex is rapidly degraded in a process that likely involves
ubiquitin-mediated endocytosis [38]. A paralogous transport-
er complex encoded by FET5 and FTH1 is expressed on the
vacuolar membrane and functions in the transfer of vacuolar
iron to the cytosol [39]. The reductive uptake system does
not appear to be necessary for all fungi, however, as
Aspergillus nidulans does not express a reductive system of
iron uptake and, correspondingly, no orthologues of FET3 or
FTR1 have been identified in this genome [40].
Fig. 2. Biosynthesis of hydroxamate siderophores in fungi. The first committed
step in hydroxamate siderophore synthesis is the hydroxylation of the amino
acid ornithine to N5-hydroxyornithine. This step is carried out by ornithine N5-
oxygenase, which was initially characterized as the product of Sid1 inU. maydis,
and has subsequently been identified in several fungal species that are known to
secrete hydroxamate siderophores. The second biosynthetic step results in the
formation of the hydroxamate group, and is accomplished by acylation of the
N5-hydroxyornithine. Specific N5 acyltransferases have not been identified, and
cellular enzymes with broad substrate specificities that function in multiple
biosynthetic pathways may carry out this step. Finally, the hydroxamates are
linked by nonribosomal peptide synthetases. Both the peptide linkages and ester
linkages of the ferrichromes and fusarinines, respectively, are carried out by
nonribosomal peptide synthetases, which are large multienzyme complexes that
participate in the synthesis of a variety of peptidyl metabolites. Direct ester
linkage of the hydroxamates results in the synthesis of fusarinines, which are
then acylated and cyclized to form triacetylfusarinine C. Formation of
ferrichromes requires the peptide linkage of glycines, and serine or alanine as
well as hydroxamates to form the cyclic hexapeptides. In addition to Sid2 and
SidC, A. nidulans, A. fumigatus, and the basidiomycete Omphalotus olearius
express additional nonribosomal peptidylsynthetases in response to iron
deprivation [96–98]. Reproduced with permission [51].
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When iron is freely available to yeast, high-affinity iron
uptake systems are not expressed and iron uptake occurs
primarily through low affinity transporters of low specificity.
Yeast express three members of the Nramp family of divalent
metal transporters, Smf1p, Smf2p, and Smf3p [41]. Nramp
family members include DMT1, the mammalian ferrous iron
transporter, and are represented in many organisms. Smf1p
and Smf2p are primarily manganese transporters involved in
the delivery of extracellular manganese and intramicrosomal
manganese to the cytosol, respectively [42]. Smf1p can
transport ferrous iron when expressed in Xenopus oocytes,
and yeast cells overexpressing Smf1p accumulate higher
levels of intracellular iron [43]. Smf3p is expressed in
vacuoles in response to iron deprivation or oxygen depletion
and is thought to transfer vacuolar stores of iron to the
cytosol [42].
Fet4p is another low affinity transporter with activity
towards ferrous iron, zinc, copper and cadmium [44–46].
Levels of this transporter increase dramatically in response to
oxygen depletion and Fet4p may constitute the primary system
of iron uptake in hypoxic or anaerobic environments [31,47]. At
low oxygen tension, ferrous iron transport systems become
independent of surface reductases because extracellular iron is
present in the ferrous form. Furthermore, the high-affinity
Fet3p/Ftr1p transporter cannot operate in the absence of
oxygen.
4. Non-reductive uptake systems: The siderophore–iron
transporters
Most fungi synthesize and secrete siderophores, which are
small organic compounds that bind ferric iron with tremen-
dous affinity and specificity [48]. Fungal siderophores bind
iron with dissociation constants of approximately 10−29 M,
which corresponds to an affinity that is orders of magnitude
greater than any other biologically relevant iron ligand.
Virtually all fungi express a non-reductive uptake system
that is specific for siderophore iron chelates [49]. Many fungi
express transporters with specificities for siderophores secreted
by other species of fungi and even for siderophores of
bacterial origin. Although the reductive system of transport
can catalyze the uptake of siderophore-bound iron, this system
is most efficient when the siderophores are relatively
abundant. At lower concentrations, uptake of siderophores
occurs primarily through siderophore-specific transporters
[50]. Although S. cerevisiae does not synthesize or secrete
siderophores, more than half of the genes transcriptionally
activated during iron deprivation are directly or indirectly
involved in the uptake of these iron chelates. One explanation
for this observation is that S. cerevisiae evolved in an
environment that was populated by many other species of
microorganisms and was rich in siderophores. Clearly, these
uptake systems enable fungi to effectively compete with other
microorganisms for the limiting amounts of available iron, and
also allow pathogenic fungi to compete for host iron.4.1. Biosynthesis of siderophores
S. cerevisiae does not synthesize or secrete siderophores, yet
this process occurs in many species of fungi and has been
studied at the molecular genetic level in Ustilago maydis and
Aspergillus sp. The process of siderophore biosynthesis [51,52]
and the biochemistry of siderophore iron binding [53] have been
reviewed and will be briefly summarized here. Fungi primarily
synthesize siderophores of the hydroxamate type, which include
the ferrichromes, the fusarinines, and coprogen, and a summary
of the biosynthetic pathway is presented in Fig. 2 [51,54]. The
first committed step in hydroxamate biosynthesis is the N5-
hydroxylation of ornithine. This step is carried out by ornithine
N5-oxygenase, which was initially characterized as the product
of Sid1 in U. maydis [55]. This enzyme was subsequently
Fig. 3. Phylogenetic analysis of fungal siderophore transporters. Siderophore
transporters of known substrate specificities were subjected to phylogenetic
analysis using the best tree neighbor joining method. Transporters from S.
cerevisiae (Sc, red), C. albicans (Ca, green), A. nidulans (An, blue), and S.
pombe (Sp, purple) are shown. Substrates for each transporter are indicated. (For
interpretation of the references to colour in this figure legend, the reader is
referred to the web version of this article.)
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dffA in A. oryzae [57]. Genes with homology to U. maydis Sid1
and A. nidulans SidA have been identified in many fungal
species, although not in S. cerevisiae nor in C. albicans.
Surprisingly, the Schizosaccharomyces pombe genome contains
an ortholog of Sid1, and although this species was reported not
to secrete siderophores, S. pombe was recently shown to
accumulate and excrete ferrichrome [58]. The second biosyn-
thetic step results in the formation of the hydroxamate group,
and is accomplished by acylation of the N5-hydroxyornithine.
Finally, the hydroxamates are linked, along with serine and
glycine, by nonribosomal peptide synthetases. Both the peptide
linkages and ester linkages of the ferrichromes and fusarinines,
respectively, are carried out by nonribosomal peptide synthases,
which can participate in the synthesis of a variety of peptidyl
metabolites.
A. nidulans synthesizes two types of hydroxamate side-
rophores, triacetylfusarinine C (TAFC), which is secreted, and
ferricrocin, which is retained intracellularly [59]. Intracellular
siderophores have been described in several fungal species,
where they function as iron storage molecules. Both S.
cerevisiae and S. pombe can accumulate large, stable,
intracellular pools of ferric ferrichrome, indicating that side-
rophores can serve as intracellular iron storage compounds in
these species as well [58,60]. Little is known regarding the
subcellular localization of siderophore synthesis and the
mechanism of siderophore excretion, but the synthesis and
storage of intracellular apo-siderophores must be precisely
controlled, as these molecules can potentially chelate cellular
iron. Siderophores secreted by pathogenic fungi can effectively
compete with host iron-binding proteins for ferric ligands. A.
fumigatus primarily secretes triacetylfusarinine C (as well as
small amounts of ferricrocin), and these siderophores can
deferrate transferrin present in serum [61]. Correspondingly,
this species depends on siderophore biosynthesis for virulence,
while reductive iron uptake is dispensable for virulence [56,62].
4.2. Uptake of siderophores
In fungi, siderophore–iron chelates are taken up through
transporters of the ARN/SIT subfamily of the major facilitator
superfamily. These are secondary transporters with 14 predicted
transmembrane domains, and they likely function as proton
symporters energized by the membrane potential [63]. Transient
membrane depolarization or inhibition of the plasma membrane
proton ATPase can block siderophore uptake in Neurospora
crassa [64]. Recent examination of fungal databases revealed
approximately 140 sequences homologous to ARN/SIT family
members in Ascomycetes and 18 related sequences in
Basidiomycetes. The siderophore transporters are also one of
17 gene families that are unique to fungi, and are not represented
in prokaryotes or other eukaryotes [49]. Accordingly, membrane
uptake systems for fungal or bacterial siderophores have not
been identified in multicellular eukaryotes, although uptake of
siderophore-bound iron has been reported to occur in mammals.
Fungal siderophore transporters were initially characterized
in S. cerevisiae, and have now been characterized in severalfungal species, including C. albicans, S. pombe, and A.
nidulans. Each transporter exhibits specificity towards a
different group of fungal and/or bacterial siderophores, although
some variation in the specificity of individual transporters has
been reported among different strains of S. cerevisiae [50]. This
yeast expresses four siderophore transporters in response to iron
depletion. Three of these transporters exclusively recognize
siderophores of the tri-hydroxamate class and one is specific for
the catecholate enterobactin. Arn1p transports ferrichrome and
related hydroxamates of the ferrichrome type, such as
ferrichrome A, ferricrocin, ferrirhodin, ferrichrysin and ferrir-
ubin [22,65]. Arn1p also recognizes coprogen [64], and it
exhibits a trace of activity towards triacetylfusarinine C (TAFC)
[22]. TAFC differs from the other hydroxamate siderophores in
that the hydroxamate moieties are joined by ester linkages,
rather than by peptide linkages [52]. Arn2p/Taf1p specifically
takes up TAFC, and shows no specificity towards other
siderophores [22,66]. Arn3p/Sit1p exhibits the broadest range
of substrate specificity, and recognizes a variety of ferri-
chromes, coprogen, and the bacterially derived ferrioxamines
[21,64,67]. Arn3p/Sit1p exhibits a trace of activity towards
TAFC, as well. None of these transporters recognizes
rhodotorulic acid, a dihydroxamate siderophore that binds
iron in a Fe2RA3 complex. Arn4p/Enb1 exclusively recognizes
enterobactin, a catecholate siderophore synthesized in bacteria,
and shows no activity towards hydroxamate siderophores
[20,68]. Substrate specificities for the C. albicans, S. pombe,
and A. nidulans transporters have been determined by
heterologous expression of the individual transporters in a S.
cerevisiae mutant strain in which both the siderophore
transporters and the high-affinity ferrous iron uptake systems
have been deleted [69–71]. The capacity of the heterologous
transporter to stimulate growth or uptake of radiolabeled iron in
the presence of a particular siderophore indicates the specificity
of the transporter. Fig. 3 depicts a phylogenetic analysis of
fungal siderophore transporters that have been characterized.
The reported substrate specificities of each transporter are
noted. This analysis makes clear that the specificity of a
transporter for a particular substrate cannot be predicted on the
basis of sequence similarity, as transporters of differing
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transporters of similar specificity from different organisms. The
siderophore transporter of C. albicans has been shown to be
required for virulence in a human cell model of epithelial
invasion, but not in a mouse model of systemic infection
[72,73]. In A. fumigatus, synthesis and uptake of siderophores
through the non-reductive uptake system is required for
virulence in mouse models of systemic infection [56,62].
4.3. Intracellular trafficking of siderophore transporters
The Arn1p and Arn3p/Sit1p transporters of S. cerevisiae
were initially found to be expressed on intracellular vesicles
rather than on the plasma membrane [21,22], and subsequent
studies have revealed that these transporters undergo precise
changes in cellular location that are controlled in part by the
concentration of their specific siderophore substrates [74,75].
These studies have primarily focused on the ferrichrome-
specific Arn1p transporter, and indicate that the activity of
Arn1p is post-translationally regulated and that the mecha-
nism of ferrichrome uptake through Arn1p entails precise
trafficking steps within the late secretory pathway. In yeast,
integral membrane proteins destined for the late secretory
pathway are sorted at the late Golgi to either secretory
vesicles destined for the plasma membrane or to vesicles of
the vacuolar protein-sorting pathway [76]. The vacuolar
protein sorting pathway and the endosomal pathway intersect
at or before the late endosomal/prevacuolar compartment,
which is also termed the multivesicular body (MVB) because
vesicles bearing cargo proteins destined for degradation in the
vacuole are sorted into the lumen of the MVB. Studies of
trafficking within the yeast secretory pathway have been
accomplished through a variety of genetic and biochemical
approaches, including the use of temperature-sensitive mutant
strains that exhibit conditional blocks at various points in the
trafficking pathway. These strategies have been used to study
the trafficking of Arn1p.
As S. cerevisiae does not synthesize or secrete endogenous
siderophores, growth of this species in an iron-depleted
environment that is also devoid of other microorganisms or
their products results in the expression of siderophore
transporters in the absence of their siderophore substrates.
The cell responds to this futile and potentially hazardous
situation by not sending Arn1p to the plasma membrane and
instead sorting Arn1p directly from the late Golgi to the vacuole
for degradation, with Arn1p accumulating only transiently in
the late endosome/MVB (Fig. 4A). Evidence supporting this
trafficking is three-fold. Inhibition of the endocytic pathway
using either a temperature-sensitive mutant strain or treatment
with an actin-depolymerizing agent indicate that Arn1p does not
transiently localize to the plasma membrane en route to the late
endosome [74]. Blocking exit from the late endosome/MVB
using a different temperature sensitive mutant prevents Arn1p
degradation and results in the accumulation of Arn1p in an
enlarged prevacuolar compartment. Finally, expression of
Arn1p in a strain that is defective in vacuolar protein
degradation results in the accumulation of Arn1p in the lumenof the vacuole (Y. Kim and C. Philpott, unpublished observa-
tions). This trafficking pathway is shared by many integral
membrane proteins in yeast and appears to be a “default”
pathway, as proteins lacking targeting information exhibit this
type of sorting [77]. Sorting of Arn1p into the lumen of the
multivesicular body appears to be dependent on ubiquitination
(Y. Kim and C. Philpott, unpublished observations). How does
the cell benefit from the transcription and translation of a
ferrichrome transporter only to rapidly degrade it in the absence
of substrate? One possibility is that expression of these
transporters on the cell surface is potentially hazardous to
cells, as toxic small molecules could be taken up non-
specifically. The Arn transporters of S. cerevisiae exhibit
overlapping specificities, and can transport structurally dissim-
ilar siderophores with reduced efficiency. These transporters are
likely to take up other small molecules as low-affinity
substrates, and excluding these substrates could be quite
advantageous to cells.
When ferrichrome is available to yeast cells, the trafficking
of Arn1p changes (Fig. 4B). Sub-micromolar concentrations of
ferrichrome induce the relocalization of Arn1p from the
endosome to the plasma membrane, indicating the presence of
a high-affinity receptor for ferrichrome [74]. Two lines of
evidence suggest that the ferrichrome receptor is part of the
Arn1p transporter. First, while cells devoid of Arn/Sit
transporters do not exhibit high-affinity binding of ferrichrome
at the cell surface, cells expressing Arn1p on the surface do
exhibit ferrichrome binding [60]. Kinetic studies have demon-
strated that Arn1p contains two externally directed sites for
ferrichrome binding, one site with an affinity similar to the KT
for transport (KD=1.2 μM) and a second site of higher affinity
(KD=8 nM). The first site likely corresponds to the binding site
for the transported siderophore, but the nature of the high-
affinity site was mysterious. Subsequent investigations revealed
that mutations within a carboxyl-terminal extracellular domain
of Arn1p eliminated both the high-affinity binding site and the
capacity of the transporter to relocalize to the plasma membrane
in the presence of ferrichrome [75]. These data suggested that
the high-affinity binding site for ferrichrome acted as a receptor,
and that the binding of ferrichrome to Arn1p at this site
triggered the redirection of Arn1p from the endosome to the
plasma membrane. How does extracellular ferrichrome gain
access to Arn1p located in the endosome? The most probable
mechanism is the internalization of soluble ferrichrome through
fluid-phase endocytosis, which is a highly dynamic process in
yeast cells. Endocytic vesicles containing ferrichrome can fuse
with Arn1p-containing vesicles in the early endosome, allowing
the ferrichrome to interact with the high-affinity binding
domain. In support of this model, pre-treatment of cells with a
drug that inhibits endocytosis prevents the ferrichrome-induced
relocalization of Arn1p to the plasma membrane [60]. How does
the intracellular trafficking machinery recognize that Arn1p has
ferrichrome bound to the high-affinity site? The cellular
components required for the diversion of Arn1p to the plasma
membrane are not known, but a cluster of phenylalanine
residues on the cytoplasmic carboxyl-terminal tail of Arn1p
may play a role. Mutation of three phenylalanine residues in the
Fig. 4. Trafficking of the ferrichrome transporter, Arn1p. In the absence of ferrichrome (A), Arn1p is sorted directly from the late Golgi to the vacuole for degradation
and accumulates transiently in the late endosome. Arn1p likely cycles through the early endosome, either directly from the late endosome (shown) or via retrieval to the
late Golgi. When ferrichrome is present in the medium (B), ferrichrome is internalized through fluid phase endocytosis (step 1), where it encounters Arn1p in the early
endosome and binds to the receptor domain. Ferrichrome binding triggers the relocalization of Arn1p to the plasma membrane (step 2), where a second molecule of
ferrichrome can bind to the transport domain of Arn1p (step 3). Ferrichrome binding at the transport domain triggers the ubiquitination of Arn1p, leading to the
internalization of the transporter (step 4). In the endosome, ferrichrome bound at the transport domain is translocated to the cytosol where the iron is released from the
siderophore (step 5), likely through degradation of the ferrichrome.
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does prevent the ferrichrome-induced relocalization to the
plasma membrane [75].
In the presence of sub-micromolar levels of ferrichrome,
Arn1p is poised on the plasma membrane to take up
siderophore. At concentrations of ferrichrome above the
threshold for uptake (KT≈1 μM), Arn1p transports ferri-
chrome, and Arn1p is internalized and recycled to the plasma
membrane. Evidence for this recycling comes from localiza-
tion studies in which strains exposed to higher concentrations
of ferrichrome expressed Arn1p on both the plasma membrane
and on endocytic vesicles, and the Arn1p could be trapped on
the plasma membrane by blocking endocytosis [74]. This
recycling appeared to be important for ferrichrome transport,
as mutant strains with defects in endocytosis also exhibited
defects in ferrichrome uptake. One model to explain thistrafficking step posits that ferrichrome binding at the transport
site is a trigger for endocytosis. Arn1p is ubiquitinated at
higher ferrichrome concentrations [75], and ubiquitination is
required for the endocytosis of several plasma membrane
proteins in yeast [78]. The purpose of the endocytosis and
recycling of Arn1p is not known, but may reflect a
requirement for the lipid environment of the endosome rather
than that of the plasma membrane, which could facilitate the
conformational changes necessary for the transporter to
operate. Although the intracellular trafficking of Arn1p
seems complex and unique, the post-translational regulation
of metal transporters through regulated intracellular trafficking
is increasingly recognized as a common mechanism to control
transport activity. Whether other siderophore transporters
under this substrate-regulated intracellular trafficking is not
known, but the ferrichrome transporter of C. albicans localizes
643C.C. Philpott / Biochimica et Biophysica Acta 1763 (2006) 636–645to both the plasma membrane and to intracellular vesicles, and
treatment of cells with ferrichrome increases the fraction of the
transporter on intracellular vesicles [73].
4.4. The fate of intracellular siderophores
Iron taken up in the form of a siderophore chelate must
be released from the siderophore ligand before being used in
cellular metabolism. In fungi that synthesize intracellular
siderophores, which are not secreted, iron is transferred from
the internalized siderophore to the intracellular siderophore
for storage [79]. Release of iron from intracellular side-
rophores may be accomplished through a reduction of the
iron-siderophore chelate, as a fluorescently labeled ferri-
chrome analog taken up by U. Maydis accumulates in
intracellular vesicles in the deferrated form [80]. This non-
destructive mechanism of iron release permits the resecretion
of the apo-siderophore. In A. nidulans and Mycelia sterilia,
iron is released from intracellular TAFC by hydrolysis of the
ester bonds, and the resulting fusarinines are resecreted
[59,81]. In S. cerevisiae, ferric-ferrichrome is taken up and
remains stable in the cytosol as an iron storage molecule
[60]. Release of iron from cytosolic ferrichrome occurs at
the same rate as the release of aluminum (III), a non-
reducible ligand, suggesting that reduction is not required
for iron release in this species. Accordingly, deferrated
ferrichrome does not accumulate intracellularly and is not
secreted by S. cerevisiae. Enzymes that catalyze the
reduction or degradation of intracellular siderophores have
not been identified.
5. Heme transport in fungi
Most of the iron in a mammalian host is in the form of
heme, and the vast majority of cellular heme is found bound
to hemoglobin within erythrocytes. Therefore, it is not
surprising that pathogenic fungi can use heme as a
nutritional source of iron. The growth of both C. albicans
[82,83]and Histoplasma capsulatum [84] is stimulated by the
addition of hemoglobin or hemin to iron-depleted culture
medium, and C. albicans expresses both hemolytic factors
and surface receptors for hemoglobin [85,86]. Although
transport systems for heme have yet to be identified in
fungi, C. albicans takes up heme as an intact molecule,
which is then degraded by intracellular heme oxygenase
[82,87]. This degradation of heme, catalyzed by CaHmx1p,
is required for cells to use heme iron for growth. The heme
uptake system of C. albicans also appears to be independent
of the reductive uptake system, as mutant strains bearing
deletions of CaCCC2 or CaFTR1 can use heme as an iron
source [82,83].
Heme uptake in fungi may show similarities to the uptake
system of another class of small, hydrophobic molecules,
oxysterols. S. cerevisiae takes up sterols under conditions of
low oxygen tension and heme deficiency, and uptake of
sterols requires both Dan1p, a cell wall mannoprotein, and the
ABC transporters Aus1p or Pdr11 p [88,89]. A GPI-anchoredcell surface mannoprotein, CaRbt5p, is involved in heme
uptake in C. albicans, and a related protein, CaRbt51p can
stimulate heme uptake when heterologously expressed in S.
cerevisiae [90].
6. Conclusions
This review has focused on the iron uptake systems of
fungi, with an emphasis on the well-characterized systems of
S. cerevisiae. Two themes emerge in the study of iron
acquisition in fungi, versatility and redundancy. By combin-
ing the wide substrate specificity of the reductive, ferrous
iron-specific system with the efficiency of the non-reductive,
siderophore-specific system, fungal cells can take up iron
from virtually any source found in the environment and
effectively compete with other microorganisms or a plant or
mammalian host for what is frequently the limiting nutrient
in the environment. This robust combination of uptake
systems also means that inhibition or inactivation of one
system will likely be compensated for by other systems.
Some of these iron uptake systems, such as the siderophore
transporters of the Arn/Sit family, appear to be unique to
fungi, while homologues of the reductive uptake system and
the Nramp family of transporters are present in a variety of
higher eukaryotes, including mammals.
The story of iron transport in fungi is far from complete,
however. Eukaryotic heme transport systems have only
begun to be described, yet they are very important, as all
eukaryotic cells have a requirement for intracellular heme
transport, and some exhibit uptake at the plasma membrane.
While intracellular iron can clearly be stored as a cytosolic
siderophore-bound chelate in fungi, in the absence of
siderophores, the fate of iron after it crosses the plasma
membrane remains unknown. Iron-binding molecules or
proteins analogous to the copper chaperones of yeast have
not been identified, and ascomycetes do not express
ferritins. Although siderophores have been thought to be
part of a microbial-specific iron delivery system, recent
reports indicate that mammals express siderophore-binding
proteins, called lipocalins or siderocalins, and can use
siderophore-bound iron for cellular metabolism [91,92].
Siderocalins are components of the innate immune system
that are secreted in response to infections. They exert their
bacteriostatic effects by binding and sequestering ferric
siderophores [93,94]. A mammalian receptor for lipocalin 2
that has homology to major facilitator transporters was
recently identified, and lipocalin-mediated delivery of iron to
cells is dependent on this receptor [95]. Studies of iron
acquisition in yeast have yielded valuable insight into
mammalian iron uptake systems as well as identifying
promising avenues for the development of anti-fungal
pharmaceuticals.
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